Hot Watch List: Cliffs Natural Resources Inc. (NYSE:CLF), Newmont Mining Corporation (NYSE:NEM), Alkermes plc (NASDAQ:ALKS), STR Holdings, Inc. (NYSE:STRI), Ariad Pharmaceuticals (NASDAQ:ARIA)

Technology Stocks News 20

Cliffs Natural Resources (NYSE:CLF) last released its earnings data on Monday, October 27th. The company reported $0.21 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.05) by $0.26. The company had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.28 billion. During the same quarter in the prior year, the company posted $0.68 earnings per share. The company’s quarterly revenue was down 16.1% on a year-over-year basis. Analysts expect that Cliffs Natural Resources will post $0.11 EPS for the current fiscal year. Cliffs Natural Resources Inc. (NYSE:CLF) belongs to Basic Materials sector. Its weekly performance is -2.91%. On last trading day company shares ended up $10.69. Cliffs Natural Resources Inc. (NYSE:CLF) distance from 50-day simple moving average (SMA50) is -0.77%.

Newmont Mining Corporation (NYSE:NEM)’s CEO Gary J. Goldberg bought 5,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, November 4th. The stock was purchased at an average price of $18.80 per share, for a total transaction of $94,000.00. Newmont Mining Corporation (NYSE:NEM) shares advanced 4.99% in last trading session and ended the day at $19.15. NEM Gross Margin is 35.80% and its return on assets is -2.30%. Newmont Mining Corporation (NYSE:NEM) quarterly performance is -28.52%.

Alkermes Plc (NASDAQ:ALKS) CEO Richard F. Pops sold 100,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $52.87, for a total transaction of $5,287,000.00. Following the completion of the sale, the chief executive officer now directly owns 520,063 shares of the company’s stock, valued at approximately $27,495,731. On 14 November, Alkermes plc (NASDAQ:ALKS) shares decreased -3.29% and was closed at $51.47. ALKS EPS growth in last 5 year was -38.50%. Alkermes plc (NASDAQ:ALKS) year to date (YTD) performance is 26.59%.

STR Holdings, Inc. (NYSE:STRI) reported a loss of 11 cents per share in the third quarter of 2014, in line with the Zacks Consensus Estimate. In the prior-year quarter, the company had reported a net loss of 12 cents per share. On a GAAP basis, the company reported a loss of 15 cents per share compared with a loss of 14 cents per share in the year-ago quarter. The difference between GAAP and operating loss was due to a loss of 3 cents associated with discontinued operations. STR Holdings, Inc. (NYSE:STRI) ended the last trading day at $1.24. Company weekly volatility is calculated as 4.83% and price to cash ratio as 1.21. STR Holdings, Inc. (NYSE:STRI) showed a weekly performance of -0.80%.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on Nov. 5 reported a third-quarter loss of $50.1 million. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 27 cents. The results topped Wall Street expectations. The average estimate of analysts was for a loss of 30 cents per share. The company posted revenue of $14.7 million in the period, which did not meet Street forecasts. Analysts expected $16.7 million. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is 1.15%. On last trading day company shares ended up $6.15. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is 7.26%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone